ReproCardio2 Assay Medium

Product Classification : Human iPS Cells Derived Cardiomyocytes

ReproCardio2 Assay Medium

Protein/lipid-free assay medium for capturing subtle drug effects in the early stage studies

  • Medium specially developed and optimized for a wide variety of assays in combination with ReproCardio2 and other cardiomyocytes
  • Serum/protein/lipid free: No absorption of compounds by proteins and lipids
  • No fluorescence: Ideal for live imaging with fluorescent calcium/voltage probes
  • Adjusted Glucose and ion levels

Volume: 100mL
Storage: 4℃


Catalog No. Product Price
RCDC301 ReproCardio2 Assay Medium (100mL) Contact us

Related Products

Catalog No. Product Price
RCDC001N ReproCardio2 Contact us
RCDC101 ReproCardio2 Culture Medium (100 mL) Contact us
RCHEOT004 ReproCoat Contact us
RCESD005 QTempo assay service Contact us


Protocol for ReproCardio2 (Jump to the download link, open in a new window)

Safety Data Sheet

ReproCardio2 publications

  • Datta-Chaudhuri, Timir, Pamela Abshire, and Elisabeth Smela. "Packaging commercial CMOS chips for lab on a chip integration." Lab on a chip 14.10 (2014): 1753-1766.
  • Datta-Chaudhuri, Timir, Pamela Abshire, and Elisabeth Smela. "Packaging commercial CMOS chips for lab on a chip integration." Lab on a chip 14.10 (2014): 1753-1766.
  • Mandenius, Carl-Fredrik, and Thomas Meyer. "High-throughput screening assays to evaluate the cardiotoxic potential of drugs." High-Throughput Screening Methods in Toxicity Testing (2013): 403-420.
  • Scott, Clay W., Matthew F. Peters, and Yvonne P. Dragan. "Human induced pluripotent stem cells and their use in drug discovery for toxicity testing." Toxicology letters 219.1 (2013): 49-58.
  • Takeuchi, Akimasa, et al. "Microfabricated device for co-culture of sympathetic neuron and iPS-derived cardiomyocytes." Engineering in Medicine and Biology Society (EMBC), 2013 35th Annual International Conference of the IEEE. IEEE, 2013.
  • Asai, Yasuyuki, et al. "Combination of functional cardiomyocytes derived from human stem cells and a highly-efficient microelectrode array system: an ideal hybrid model assay for drug development." Current stem cell research & therapy 5.3 (2010): 227-232.
  • Asai, Y. "Direct measurement of the QT interval in stem cell-derived cardiomyocytes for the assessment of QT liability." Nihon yakurigaku zasshi. Folia pharmacologica Japonica 134.6 (2009): 320-324.
  • Szebenyi, Kornelia, et al. "Human pluripotent stem cells in pharmacological and toxicological screening: new perspectives for personalized medicine." Personalized Medicine 8.3 (2011): 347-364.

ReproCardio2 in QTempo assay publications

  • Vidarsson, Hilmar, Johan Hyllner, and Peter Sartipy. "Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications."Stem Cell Reviews and Reports 6.1 (2010): 108-120.
  • Lecina, Marti, et al. "Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures." Tissue Engineering Part C: Methods 16.6 (2010): 1609-1619.
  • Phillips, Blaine W., and Jeremy M. Crook. "Pluripotent Human Stem Cells."BioDrugs 24.2 (2010): 99-108.

ReproCardio2 presentations

  • Society for Biomolecular Sciences(SBS), 14th AnnualConference & Exhibition 2008 (St. Louis), poster session, April 2008.
  • IBC Asia's 4th Annual Stem Cells Asia Congress (Singapore), oral session, June 2008.
  • ELRIG and SBS Present: Drug Discovery (UK) poster session, September 2008.
  • Advances in Stem Cell Discoveries (San Francisco) oral session, September 2008.
  • Stem Cells: Drug Discovery and Therapeutics (London) oral session, February 2008.
  • Society for Biomolecular Science 15th Annual Conference (France), poster session, Best Poster 2009 Award-winning, April 2009.
  • Stem Cells and Regenerative Medicine Europe (UK), September 2009, Best Poster 2009 Award-winning.
  • MipTec Conference 2009, October 13-15, Basel Invited Lecture.
  • The 74th Annual Scientific Meeting of the Japanese Circulation Society (Kyoto), March 2010.
  • The 130th The Pharmaceutical Society of Japan (Okayama), March 2010.
  • The Society of Toxicology (SOT) 51st Annual Meeting (CA, USA), poster session, March 2012.
  • Safety Pharmacology Society (SPS), 13th annual meeting 2013 (Rotterdam, Netherlands), poster session, September 2013.
  • Automated Patch-Clamp systems and Ion Channel Expressing Cells 2013 (Tokyo), Verbal presentation 2013 Nov.
  • The 7th Takeda Science Foundation Symposium (Osaka), Poster presentation 2014 Jan.